The document describes three case scenarios involving newborn infants with respiratory distress. The first case involves an infant born at 30 weeks gestation who developed respiratory distress soon after birth and was normothermic, euglycemic, and had good reflexes and activity. The second case involves an infant born at 31 weeks gestation who was started on oxygen and later developed progressive respiratory distress, with CPAP initiated after the Downe's score reached 5 at 3 hours of age. The third case involves an infant born at 30 weeks gestation who was initially put on CPAP but required increased settings and eventually surfactant and mechanical ventilation due to inability to maintain saturation on CPAP. The document seeks management recommendations for each case.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Newborn Care was written for healthcare workers providing special care for newborn infants in level 2 hospitals. It covers: resuscitation at birth, assessing infant size and gestational age, routine care and feeding of both normal and high-risk infants, the prevention, diagnosis and management of hypothermia, hypoglycaemia, jaundice, respiratory distress, infection, trauma, bleeding and congenital abnormalities, communication with parents
This presentation deals with the basic physics of human ventillation. I have made an effort to clarify most of the venti lingo , so as to make way for further discussions on ventilator use. Hope it turns out to be helpful for you. Thank you.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Newborn Care was written for healthcare workers providing special care for newborn infants in level 2 hospitals. It covers: resuscitation at birth, assessing infant size and gestational age, routine care and feeding of both normal and high-risk infants, the prevention, diagnosis and management of hypothermia, hypoglycaemia, jaundice, respiratory distress, infection, trauma, bleeding and congenital abnormalities, communication with parents
This presentation deals with the basic physics of human ventillation. I have made an effort to clarify most of the venti lingo , so as to make way for further discussions on ventilator use. Hope it turns out to be helpful for you. Thank you.
CLINICAL TEACHING ON BUBBLE CPAP: Introduction, Definition, History of development, Physiology of Bubble CPAP, Principle, Patient interface, equipments for bubble CPAP, indication and contraindication for bubble CPAP, essential of CPAP, CPAP machine, bubble cpap machine application, setting pressure, FiO2, oxygen flow, Monitoring adequacy and complications of bubble CPAP, Monitoring infant condition, weaning for Bubble CPAP, CPAP Failure, complications related to CPAP, Preventing complications, Nursing Care.
How to resuscitate, management in meconium aspirated baby, thin and thick meconium, ratio of ventilation and perfusion in new born, latest change in guidelines for resuscitation
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria YasminDr. Habibur Rahim
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Duct-dependent systemic circulations
Critical aortic stenosis
Coarctation of the aorta
Interruption of aortic arch
Hypoplastic left heart syndrome
Duct-dependent pulmonary circulations
Pulmonary atresia Critical pulmonary stenosis
Tricuspid atresia
Tetralogy of Fallot
Ebstein’s anomaly
Parallel non-mixing circulation
Transposition of great arteries
Other
Total anomalous pulmonary venous connection (TAPVC)
Double outlet right ventricle
Single ventricle
Truncus arteriosus
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. Case scenario :1
A male baby weighing 1050 gm born to a 20 years old lady of para
1+0. She got admitted in BSMMU at 30 weeks gestation due to PET
and emergency LUCS done. Mother got single dose of antenatal
corticosteroid 12 hours before LUCS. Baby cried immediately after
birth & APGAR was good. Baby developed respiratory distress soon
after birth in the form of grunting and chest indrawing. Baby was
normothermic, euglycemic, reflex & activities were good.
What would be the optimum respiratory
management in delivery room?
2. Case Scenario: 2
• D/O Morium, inborn, got admitted in NICU at 10
minutes of her age due to prematurity (31weeks),
VLBW(1270g) and respiratory distress. The baby was
started O2 2L/min on the basis of Downe score 3. Later
on, the baby developed progressive respiratory distress
DOWNE’s Score became 5 at post natal age 3 hours
CPAP was initiated
Could we start CPAP earlier ?
IS there any alternative modalities other than CPAP ???
3. Case Scenario: 3
• D/O Sayeda, 30weeks, 1175g, inborn, got admitted in NICU at 10
minutes of her age due respiratory distress and DOWNE score was
5. Initially baby put on CPAP. As the baby couldn’t maintain
saturation CPAP settings were increased. She got Surfactant
therapy at 2 hours and put on Mechanical ventilation. At the age
of 120 hours baby was on low set up of MV-SIMV (pressure 10/5
cm of H20,Rate 20 b/m,Fio2 21%) and other clinical parameters
were good and extubation was planned.
What would be the next respiratory management after
extubation?
4. Non Invasive
Respiratory Support in newborn
Dr. Rahila Begum
Resident, Year – 1
Department of Paediatric Gastroenterology and nutrition
Dr. K.M.Mahbubur Rahman
Resident, Year – 3
Department of Neonatology
BSMMU
5. Content outline
• Supplemental O2 delivery apparatus.
• Different modalities of respiratory support.
• Different types of non invasive respiratory support.
• Delivery room management of respiratory distress.
• Evidences on current use of non invasive modalities.
8. Nasal prong / Nasal Cannula
• Disposable plastic device that
ends in 2 short tapered tubes
• Standard flow rate: 0.5–1 L/min
Advantages
• No risk of gastric
distension
Disadvantages
• Airway obstruction
• Dislodgement
• Skin irritation or breakdown
Oxygen therapy for Children- World Health Organization. 2016
9. Nasal Catheter
• Thin, flexible tube, passed into the
nose and ends with its tip in the
nasal cavity.
• Distance: Side of the nostril to inner
margin of eyebrow
• Maximum flow rate: 0.5–1 L/min
Advantage:
• Well tolerated
• Unlikely to be dislodged
Disadvantages:
• Block with mucus leads to
upper airway obstruction
• Gastric distension
Oxygen therapy for Children- World Health Organization. 2016
10. Nasopharyngeal catheters
• Inserted into the nose to
a depth 1 cm less than
the distance from the
side of the nose to the
front of the ear (tragus).
• Maximum flow rate 0.5
- 1 L/min
Advantages:
• Cost effective
• Better oxygenation
Disadvantages:
• Drying of the nasal mucosa, bleeding
and airway obstruction.
• Gastric distension
Oxygen therapy for Children- World Health Organization. 2016
11. • An oxygen hood (cube) that
surrounds the head of the
neonate, to provide continuous
flow of humidified oxygen.
• Flow rate 3 – 10 L/min.
Head box
Advantage:
• Less risk of airway
obstruction or gastric
distension.
Disadvantage:
• Carbon dioxide toxicity
if inadequate oxygen
flow
Oxygen therapy for Children- World Health Organization. 2016
12. Face mask
• Flexible, plastic or
rubber that can be
molded to fit the face
• Not used in neonates
Holding O2 Source Near
The Infant’s Face
Used for short periods-
• After extubation
• During breast feeding
Oxygen therapy for Children- World Health Organization. 2016
13. Supplemental Oxygen via Incubator
• Most common method of low-level
supplemental O2 delivery in Europe
• These incubators have respiratory
gas connection ports, a
microprocessor, and an oxygen
sensor that control O2 content
Advantages:
• Provides steady oxygen
• Avoids skin breakdown
• Noise is low
Disadvantage:
• Infant must be
maintained in an
incubator
15. The basic goal of using these devices
To recruit collapsed alveoli and terminal
airways
Maintain end-expiratory lung volume
Preserve gas exchange
Minimize
work of
breathing
Assisted Ventilation of the Neonate
6th Edition
16. WHY NON INVASIVE
RESPIRATORY
SUPPORT?
Less volutrauma and less Barotrauma
Avoid “ventilator associated Pneumonia, subglottic stenosis
and tracheal lesions
Avoid cardiovascular and cerebrovascular instability related to
intubation
17. Non invasive respiratory support(NIRS)
NIRS
Typical
Non Typical
eg. HHHFNC
CPAP NIMV/NIPPV NHFV
NIV-NAVA
18. Continuous Positive Airway Pressure
Application of positive
pressure to airway of a
spontaneously breathing
infant throughout the
respiratory cycle.
Most widely used CPAP is Bubble CPAP
Types:
1) Continuous Flow CPAP
- Ventilator derived CPAP
- Bubble CPAP
2) Variable Flow CPAP
- Infant Flow Driver
- Sigh Intermittent Positive Airway Pressure (SiPAP)
Gas source with 02
blender
Humidification
chamber
Pressure generator
Nasal interface
19. Indications
ABG Criteria:
FiO₂ requirement >0.40 to
maintain PaO₂ .50 mm Hg
Clinical Conditions:
•Respiratory disorders
•Apnea of prematurity
•Disorder causing excessive
lung fluid
•Laryngo/tracheomalacia
•Post extubation
Management protocol of newborn, NICU,
BSMMU, January 2016
Contra-indications
Assisted Ventilation of the Neonate
6th Edition
•Poor respiratory drive
•Congenital malformations
•Severe cardiovascular
instability
•Severe apnoeic episode
• Ventilatory impairment (PH
< 7.25, PCO2>60)
21. Timing of CPAP Initiation
• Prophylactic CPAP in delivery room
• Early : within 2 hours of distress
• Late : If FiO2 requirement > 0.40
CPAP does not work as
expected if it is started
after atelectasis have
been already occurred.
Early CPAP enhances
- surfactant conservation
- lower PEEP
- reduce the need for MV
Assisted Ventilation of the Neonate
6th Edition
22. CPAP Setting
• Set up is disease specific.
• Pressure ranges 4 – 7 cmH2O
• FiO2 0.21 – 0.60
• Flow rate 2 – 8 L/min
General rules of initial setup is rules of “5”.
- Pressure: 5 cmH2O
- FiO2: 0.50
- Flow: 5 L/min
Always insert orogastric tube while baby on CPAP and keep
open & above the level of stomach
23. How to assess optimum CPAP?
• Clinical:
Baby is comfortable in CPAP
Reduced respiratory distress
Normal CRT & BP
Maintain SpO₂ within 90 – 95%
• Chest X-Ray: Optimum chest expansion.
• Arterial blood gas:
pH: 7.30 – 7.40
PCO₂: 40 – 45 mm Hg
PO₂: 60 – 80 mm Hg
Management protocol of newborn, NICU,
BSMMU, January 2016
24. Adjustment CPAP Settings
• ↑ PEEP by 1 cmH20 in every 15 to 20 min to maintain
SpO2 between 90 – 95%
• Adjust PEEP by seeing the chest retraction. Increase
PEEP upto 8 cmH2O
• Do not raise FiO2 before pressure.
• ↑ FiO2 upto 0.60 to maintain SpO2
• No bubbling inadequate flow to generate pressure
or may be leak in circuit.
• Excess bubbling wastage of gases or turbulence in
flow.
Assisted Ventilation of the Neonate
6th Edition
25. CPAP Weaning
• Weaning should be slow and steady.
• Every 1 cm H₂O decrease in CPAP aims to decrease
FiO₂ 10%.
• When baby comes down to PEEP 5 & FiO2 50% then
first decrease FiO₂ upto 30% and then decrease
pressure from 5 to 4 cm H₂O.
• When pressure 4 and FiO₂ < 30% with normal SpO₂
and minimal retraction, CPAP may be weaned to air
or head hood.
Assisted Ventilation of the Neonate
6th Edition
26. CPAP Failure
• Presence of retraction / grunt
• Recurrent or severe apnoea ( ≥ 3 apnoea/ hour or
that requiring bag & mask ventilation)
• PO₂ < 50 mm Hg in FiO₂ >0.60
• PCO₂ > 60 mm Hg or pH < 7.25
Management protocol of newborn, NICU,
BSMMU, January 2016
27. Complications of CPAP
• Pulmonary air leak syndrome
• Decreased cardiac out put
• Impedance of pulmonary blood flow with increased
pulmonary vascular resistance
• Gastric distension & CPAP belly syndrome
• Nasal irritation, damage to the septal mucosa, skin
damage and necrosis from fixing devices.
Assisted Ventilation of the Neonate
6th Edition
28. Trouble Shoot in CPAP
SpO2 Retraction Air entry Bubbling Diagnosis
Low +++ Poor Yes Lung disease
Low +/nil Good Yes PPHN/CHD
Normal +++ Good Yes Metabolic acidosis
Low +++ Poor Yes Obstruction
Low +++ Poor Nil Leaks
29.
30. • Conclusion: Using CPAP immediately after birth with
subsequent selective surfactant administration
considered as an alternative to routine intubation
with prophylactic or early surfactant administration
in preterm infants.
31. Early CPAP versus Surfactant in Extremely Preterm Infants.
NEJM. 2010; 362(21). SUPPORT trial
Conclusion:
No significant difference in the primary outcome of
death or bronchopulmonary dysplasia between two
groups.
CPAP results lower rate of intubation, reduced rate of
postnatal corticosteroid use, shorter duration of
ventilation without an increased risk of any adverse
neonatal outcome.
Data supports CPAP as an alternative to routine
intubation and surfactant administration in preterm
infants.
32. SANDRI et a. Prophylactic or Early Selective Surfactant Combined
With nCPAP in Very Preterm Infants. PEDIATRICS.2010;125(6).
CURPAP trial
CONCLUSIONS:
• Prophylactic surfactant was not superior to nCPAP.
• Early selective surfactant decreases the need for MV
in the first 5 days of life and the incidence of main
morbidities of prematurity in spontaneously
breathing very preterm infants on nCPAP.
33. Use of Bubble Continuous Positive Airway Pressure (BCPAP) for
Prevention of Respiratory Distress in Preterm Infants
Dr. Mohammed Shaheen ,Department of Neonatology
Bangabandhu Sheikh Mujib Medical University (BSMMU Dhaka .October: 2014
Conclusion: Prophylactic use of Bubble CPAP did not show any significant
distress in preterm infants of 28-32 weeks gestation.
Therefore, unnecessary intervention can be avoided in a group of preterm
infants who make up a large proportion of those admitted to neonatal
intensive care units.
34. Other CPAP devices
Infant Flow Driver:
This device generate CPAP at the airway proximal to infants
nose.
Principles:
- Bernoullis effect (maintain constant pressure)
- Venturi effect (flow variation acc. to baby needs)
- Coanda effect (causes fluidic flip & hence ↓ WOB)
35. Sigh Intermittent Positive Airway Pressure (SiPAP)
• It is newer mode of NIV
which provides bilevel CPAP
• SiPAP is not a nasal IMV
• Small (2-3 cmH2O), slow,
intermittent increase in
CPAP pressure for duration
up to 3 sec →sigh breath.
• SiPAP setting:
- Baseline CPAP level
- Frequency (usually 6)
- Pressure rise (2-3 cm H2O)
- Duration of pressure rise (1-
2 sec)
• Two pressure settings: Inhalation (High pressure)Exhalation (Low pressure)
• Initial pressure setting: IPAP: 8 – 12 cm H2O EPAP: 4 – 5 cm H2O
36. Devices used for interface
• Nasal prong
• Nasopharyngeal prong
• Nasal mask
• Face mask
Widely used nasal prong.
No published data
concerning the safety and
efficacy of nasal mask.
37.
38.
39. Bipin Karki.Is nasal mask better than nasal prongs for delivering
nasal continuous positive airway pressure in preterm infants
with respiratory distress syndrome? 2018
CONCLUSION
Nasal Continuous positive airway pressure (NCPAP)
with mask interface is equally effective as nasal
continuous positive airway pressure (NCPAP) with
prongs interface. Incidence of stage II nasal trauma
was significantly lower in mask group than in the
prongs group.
40. King B.C et al. Mask versus Prongs for Nasal Continuous
Positive Airway Pressure in Preterm Infants: A Systematic
Review and Meta-Analysis,4th june 2019
Conclusions
We found low- to very-low-certainty evidence to suggest that delivering NCPAP
through the use of a nasal mask decreases the rate of NCPAP failure and the
incidence of skin injury among all infants requiring NCPAP. There were no
differences between the two interfaces with respect to mortality and other
morbidities. The current evidence supports the use of nasal masks for preterm
infants; however, further evidence is needed to improve the certainty of the
evidence, in particular with regard to the clinically significant long-term outcome of
moderate-to-severe BPD.
41. Non invasive respiratory support(NIRS)
NIRS
Typical
Non Typical
eg. HHHFNC
CPAP NIMV/NIPPV NHFV
NIV-NAVA
42. Heated Humidified High Flow Nasal Cannula(HHFNC)
• Same as CPAP but without
having in-build PEEP.
• Here PEEP is created by high
flow (3-8 L/mi) which is
dynamic pressure.
43. Why consider high Flow Nasal Cannula?
• Easier to apply than CPAP
• Greater access to the baby’s face.
May improve feeding and bonding
Less prone to nasal injury
Nursing and parental satisfaction
44. How HHFNC works?
Flushing the upper airway dead space of CO2,
Reducing inspiratory WOB
Improving lung & airway mechanics by
eliminating the effect of drying/cooling.
Reducing or eliminating the metabolic cost
of gas conditioning.
Provide end distending pressure.
45. Indications of HHFNC
• In post extubation setting
• Weaning from nCPAP
• As primary mode of support in respiratory
distress though enough evidence for safety
and efficacy lacking.
46. Protocol for initiating set up of HHFNC
• First appropriate size nasal cannula is attached to
circuit tube.
• Set FiO2 at same or 5-10% higher from previous
mode of support in post extubation cases. Start with
FiO2 0.40 in case of primary support.
• A rule of thumb for initial flow rate setting, use 1-2-3,
2-3-4, 3-4-5 formula
1 to 2 kg = 3 L/min
2 to 3 kg = 4 L/min
> 3 kg = 5 L/min
47. Maintain & weaning of HHFNC
• ↑flow rate 1 L/min if FiO2 increases > 10% and
PCO2 increases > 10 mmHg above baseline.
• Titrate flow & FiO2 to keep SpO2 between 90-
95%.
• First decrease FiO2 during weaning upto 40%
then decrease flow rate slowly by 1 L/min upto
3L/min.
• Then further decrease FiO2.
• Then wean to air or headbox/oxyhood
48. • Results :Twenty-eight babies were enrolled after written parental
consent had been obtained. 25/28 were successfully stabilised
in the DR and transferred to the NICU on nHF. The average
admission temperature for babies transferred on nHF was 36.9°C
and the average inspired oxygen at admission was 29%. Less than
half (48%) required surfactant and 60% were still on nHF 72 h
after admission
• Conclusions: using nHF for stabilisation of premature infants
in the DR and subsequent transfer to NICU is feasible
49.
50. Non invasive respiratory support(NIRS)
NIRS
Typical
Non Typical
eg. HHHFNC
CPAP NIMV/NIPPV NHFV
NIV-NAVA
51. Non Invasive Ventilation (NIV)
Synchronized & non synchronized NIMV with a
conventional ventilation is the most common form.
Short binasal prongs are the most commonly used
interface for NIPPV.
Nasal mask & nasopharyngeal prongs can be used.
NIV avoid complications of prolonged invasive
ventilator (volutrauma, infection & subglottic
stenosis.)
52. NIPPV cont…
• Short binasal prongs are the most commonly used
interface for NIPPV.
• Nasal mask & nasopharyngeal prongs can be used.
• Set up:
Short inflation times (0.3–0.5 s),
Variable inflation rates of 10–60/min and
Peak pressures and positive end expiratory pressure
similar to those used with endotracheal ventilation.
53. Nasal Intermittent Positive Pressure Ventilation
Indication:
• Failing nCPAP
• Following extubation from mechanical ventilation
•As a primary supports sometimes
Benefits:
• Improves gas exchange and ventilation
• Reduces need for intubation
• Reduces duration of invasive mechanical ventilation
• Reduces extubation failure
54. • Conclusion: NIPPV was safely and effectively used in the
delivery room settings to provide respiratory support for VLBW
infants with less need for intubation, chest compressions,
epinephrine administration and subsequent invasive ventilation.
55.
56. Non invasive respiratory support(NIRS)
NIRS
Typical
Non Typical
eg. HHHFNC
CPAP NIMV/NIPPV NHFV
NIV-NAVA
57. Neurally Adjusted Ventilatory Assist (NAVA)
• NAVA is new & unique form of
assisted ventilation.
• It can be used in both intubated
& non intubated patients.
• It controls the ventilator by
using the electrical activity of
the diaphragm (EAdi).
• EAdi signal is obtained by nine
miniaturized electrodes
embedded on a conventional
naso/oro gastric tube,
positioned in the lower
esophagus.
58.
59. Non invasive respiratory support(NIRS)
NIRS
Typical
Non Typical
eg. HHHFNC
CPAP NIMV/NIPPV NHFV
NIV-NAVA
60. Nasal High Frequency Ventilation (NHFV)
• NHFV breath can be delivered by nasopharyngeal or
nasal prongs.
• NHFV with Drager VN500 ventilator showed nearly
threefold more efficient CO2 clearance than NIMV.
• Potential advantage of NHFV over NIMV is that
synchronization is not necessary, because of
relatively high frequencies.
62. Conclusion : There is no evidence to support the non inferiority of
HFNC compared to CPAP as an initial management of respiratory
distress in premature infants at between 30 and 35 weeks
gestational age. The difference in failure rate is not significant
without an increase in the incidence of complications.
The aim : to assess the
effectiveness and safety of HFNC
compared to CPAP as a
noninvasive respiratory support
for the initial respiratory
management of respiratory
distress in preterm infants.
65. Conclusion
HFNC is non-inferior to CPAP as respiratory support after extubation of preterm
newborns with gestational age of 32 weeks or less, and has similar reintubation
rates, although its use should be cautious in extremely preterm newborns with
gestational age <26 weeks, as it is not yet possible to determine its efficacy in this
age group.
The lower risk of nasal trauma should be taken into account when choosing between
therapies. The use of HFNC appears to be safe and efficient. Multicenter studies
with different gestational ranges are required.
66.
67. HFNC
CPAP
More trials is required to find out preferable optimum
non invasive ventilation
NIPPV
Answer is
Which non invasive modality is the best?
68. Take home message
• Improvement of respiratory supports in neonatal
care have led to increased survival of smaller and
more critically ill infants.
• CPAP immediately after birth with subsequent
selective surfactant administration is an alternative
to routine intubation with prophylactic or early
surfactant administration in preterm.
• Noninvasive ventilator (NIV) support is preferred in
comparison to invasive supports.
• More research required to understand relative
benefit of various NRS mode
69.
70. References
• Rennie & Roberton’s textbook of neonatolog. 5th edition
• Neonatolog. management, procedure, no-call problems, and
drugs. 7th editiom
• Manual of neonatal care. 8th edition
• Avery’s diseases of the newborn. 7th edition
• Nelson textbook of pediatrics. 20th edition
• Assisted ventilation of the neonate. 5th edition
• CPAP bedside application in the newborn. 2nd edition
• Workshop on CPAP. Science, evidence & practice. 4th edition
• Online journal